<?xml version="1.0" encoding="UTF-8"?>
<p>Finally, the recruitment of 1499 patients was concluded a few months ago in a randomized, controlled, open-label, phase III trial of the standard of care with CQ prophylaxis compared to no prophylaxis in HIV-positive patients in Malawi (
 <xref rid="microorganisms-08-00085-t001" ref-type="table">Table 1</xref>) [
 <xref rid="B44-microorganisms-08-00085" ref-type="bibr">44</xref>,
 <xref rid="B45-microorganisms-08-00085" ref-type="bibr">45</xref>].
</p>
